Canaccord Genuity Maintains Buy on Tenaya Therapeutics, Lowers Price Target to $18
Canaccord Genuity Maintains Buy on Tenaya Therapeutics, Lowers Price Target to $18
Canaccord Genuity維持對Tenaya Therapeutics的買入,將目標股價下調至18美元
Canaccord Genuity analyst Whitney Ijem maintains Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and lowers the price target from $19 to $18.
Canaccord Genuity分析師惠特尼·伊傑姆維持Tenaya Therapeutics(納斯達克股票代碼:TNYA)的買入並將目標股價從19美元下調至18美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。